Innovative Rapid Diagnostic Technique Shortens Sepsis Detection to Hours

Researchers from the KTH Royal Institute of Technology and Uppsala University have developed a groundbreaking diagnostic method that significantly accelerates the detection of sepsis infections. Traditionally, bloodstream infections are identified over several days through bacterial culturing, a process that delays critical treatment. The new approach utilizes a smart centrifuge to separate bacteria from blood cells efficiently, followed by automatic microscopy and artificial intelligence analysis to detect bacterial presence. This method can confirm bacterial infections within approximately two hours, a stark contrast to the usual 24-72 hours needed in clinical labs.

The process involves spinning blood samples with a specialized agent to cause bacteria to float up while blood cells sediment down. The bacteria-rich liquid is then channeled into a microfluidic chip where minuscule traps capture the bacteria. Automated, time-lapse microscopy coupled with machine learning software rapidly analyzes the samples, allowing clinicians to identify pathogens swiftly.

This advance enables doctors to start targeted antibiotic therapy much earlier, which is vital since each hour of delay in treating septic shock reduces survival chances by about 8%. Currently, hospitals take at least one to four days to determine the appropriate antibiotic treatment, often leading to the use of broad-spectrum antibiotics that can harm beneficial bacteria and promote resistance.

The team's research, published in npj Digital Medicine, demonstrates high sensitivity in detecting pathogens such as E. coli, K. pneumoniae, and E. faecalis at low bacterial concentrations. However, detecting bacteria like Staphylococcus aureus, which hide in blood clots, remains a challenge and is under further investigation.

This innovative technique promises to transform sepsis diagnosis, providing faster and more accurate results that could save lives and improve patient outcomes. The collaboration highlights the potential of combining microfluidic engineering and AI to tackle crucial challenges in infectious disease diagnostics.